Blog
RSS FeedPosted by Michael Wonder on 15 Mar 2022
BeiGene and Medison announce approval and national reimbursement in Israel for Brukinsa (zanubrutinib) for the treatment of Waldenström's macroglobulinaemia
15 March 2022 - Second regulatory approval for Brukinsa in Israel. ...